Form D · Biotechnology
REVNA BIOSCIENCES, INC.
Horsham, PA · CIK 0002048552
Offering snapshot reported Dec 31, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1.9M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533829
Convertible Notes
Source: Form D, filed Dec 31, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Derrick Edem Akpalu | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
300 Welsh Road Building One, Suite 100
Horsham, PA, 19044
Horsham, PA, 19044